UNC Health Care

Tag: Lineberger

An illustration of bacteria in a person's digestive tract.

March 13, 2017

‘Good’ bacteria is possible solution for unchecked infl...

In a study published in journal Nature Immunology, researchers led by UNC Lineberger member Jenny P.Y. Ting, PhD, describe how inflammation can go unchecked in the absence of a certain inflammation inhibitor called NLRP12. In a harmful feedback loop, this inflammation can upset the balance of bacteria living in the gut. Beneficial bacterial may be the key to reversing inflammation in the absence of this key regulator.

Gastroenterology, Research

Read Article
H. Shelton Earp

March 13, 2017

Earp, Ting recognized for career achievements in cancer research

H. Shelton Earp, MD, director of UNC Cancer Care and the Lineberger Professor of Cancer Research, and Jenny P.Y. Ting, PhD, UNC Lineberger member and William Rand Kenan Professor of Genetics, have been honored with the Hyman L. Battle Distinguished Cancer Research Award.

Awards, Cancer

Read Article

March 1, 2017

UNC Lineberger launches innovative cellular immunotherapy program

The early-stage cellular immunotherapy trials are for patients with either Hodgkin lymphoma or non-Hodgkin lymphoma, who lack other treatment options or are at high risk of their disease returning.

Immunology, Innovation

Read Article
A woman's reproductive organs represented with flowers.

February 23, 2017

UNC researcher finds safer, less-invasive method of staging endomet...

Using dye to map cancer metastases, Emma Rossi, MD, and UNC collaborators lead large study to help patients avoid complications from surgery.

Cancer, Innovation, Research

Read Article
UNC Cancer Care Director H. Shelton Earp

February 16, 2017

Researchers awarded grant to study strategy to improve immunotherap...

With a $1.74 million grant from the NIH, UNC Lineberger researchers led by H. Shelton Earp, MD, will study a potential new strategy for improving immunotherapy drug responses in patients with melanoma.

Awards, Immunology

Read Article
Engineered stem cells (in blue) suspended in a gel home in on a glioblastoma tumor (in yellow) in a test-tube experiment at UNC.

February 2, 2017

Revolutionary approach for treating glioblastoma works with human c...

UNC-Chapel Hill researchers led by UNC Lineberger member Shawn Hingtgen, PhD, reach a critical milestone for treating brain cancer.

Cancer, Research

Read Article
John Sondek

December 21, 2016

Inside the world of cell signaling: a G-protein breakthrough

UNC scientists led by John Sondek, PhD, created a new biochemical tool to block specific types of downstream G-protein signaling, opening new avenues of research and potential drug design and discovery.

Gastroenterology, Studies

Read Article

December 14, 2016

Cigar warning labels are not equally believable among adolescents

Less than 50 percent of surveyed teens found it ‘very believable’ that cigars are not a safe alternative to cigarettes, according to a first-of-its-kind UNC School of Medicine study.

Families, Substance Abuse, Tobacco

Read Article
Damaged chromosomes in Atr-mutant progenitors.

November 1, 2016

Could targeting a gene linked to microcephaly lead to a better brai...

UNC Lineberger researchers led by Dr. Timothy R. Gershon report preclinical findings showing promise for targeting a gene linked to microcephaly in infants as a treatment for medulloblastoma.

Brain Cancer, Cancer, Genetics, Neurology, Treatment

Read Article
Louise Henderson

November 1, 2016

Study raises concerns about timely follow-up to positive mammogram ...

In the journal Cancer Epidemiology, Biomarkers & Prevention, researchers report that uninsured women under age 65 who received their mammogram at community screening clinics in North Carolina were less likely to get follow-up within a year of a positive mammogram, and had higher odds of missing a 60-day window for follow-up care.

Breast Cancer, Research, Social Justice, Treatment

Read Article
Charles M. Perou

October 6, 2016

Komen recognizes Charles Perou with the Brinker Award, its top scie...

Susan G. Komen announced UNC Lineberger researcher Charles M. Perou, PhD, as the recipient of this year's Brinker Award for Scientific Distinction in Basic Science for his contributions to the understanding of breast cancer as distinct molecular subtypes that have prognostic value using cutting-edge cancer genomics tools.

Awards

Read Article
Illustration of pills on top of money.

October 4, 2016

High up-front costs could delay access to life-saving blood cancer ...

In the study published in the Journal of Clinical Oncology, UNC Lineberger researchers report that nearly a third of a group of patients with chronic myeloid leukemia, and who have federally-funded Medicare health insurance, did not start treatment within six months of diagnosis with any of three targeted drugs that have led to dramatic improvements in survival for the disease.

Cancer, Hematology, Research

Read Article